Qurat-ul-ain Kamili, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 760 N Shiloh Rd, Garland, TX 75042 Phone: 972-272-4463 Fax: 972-272-7137 |
Donald F Senter, M.D. Allergy & Immunology - Allergy Medicare: Not Enrolled in Medicare Practice Location: 760 N Shiloh Rd, Garland, TX 75042 Phone: 972-272-4463 Fax: 972-272-7137 |
Michael Louis Alvares, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 760 N Shiloh Rd, Garland, TX 75042 Phone: 972-272-4463 Fax: 972-272-7137 |
Pooja K Purswani, Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 760 N Shiloh Rd, Garland, TX 75042 Phone: 972-272-4463 Fax: 972-272-7137 |
Stephen Mark Olmstead, DO Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 760 N Shiloh Rd, Garland, TX 75042 Phone: 972-272-4463 Fax: 972-272-7137 |
Richard A Page, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2380 Firewheel Pkwy, Ste. 1100, Garland, TX 75040 Phone: 972-271-6811 Fax: 972-278-6589 |
Gerald Clinton Moore, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 760 N Shiloh Rd Ste 602, Garland, TX 75042 Phone: 972-272-4463 Fax: 972-272-7137 |
Milan Sljivich, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 760 N Shiloh Rd, Garland, TX 75042 Phone: 972-272-4463 Fax: 972-272-7137 |
News Archive
Perlegen Sciences, which develops genetic tests that correlate genetic variation to disease risk and drug response, announced today that its BREVAGen™ breast cancer risk stratification test is now clinically available in select U.S. markets. Perlegen plans to add sales areas to make the test available nationwide over the next few months.
While most of us worry about the fat cells building up on the fleshy parts of our bodies, scientists have started to pay serious attention to another kind of fat cell deep inside our bones, in what's called the marrow.
Researchers based at the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Moorfields Eye Hospital and UCL Institute of Ophthalmology, received funding from Fight for Sight and the Special Trustees of Moorfields Eye Hospital NHS Foundation Trust which has resulted in the design of a new test that can spot the first stages of sight loss in age-related macular degeneration (AMD).
Cataracts, a clouding of the lens in the eye leading to vision loss, affects more than 24 million people in the United States, according to National Institutes of Health estimates. Often linked to the natural process of aging, cataracts are a major cause of blindness worldwide. K. Krishna Sharma, an ophthalmology researcher at the University of Missouri, has worked for more than two decades to study the mechanisms involved in this degenerative disease.
› Verified 4 days ago